L. McMahon, H. Tamary, M. Askin, P. Adams-Graves, R. Eberhardt, M. Sutton, et al., “A Randomized Phase II Trial of Arginine Butyrate with Standard Local Therapy in Refractory Sickle Cell Leg Ulcers,” British Journal of Haematology, Vol. 15, No. 5, 2010, pp. 516-524. doi:10.1111/j.1365-2141.2010.08395.x

has been cited by the following article:

• TITLE: Cutaneous Manifestations of Sickle Cell Disease

  AUTHORS: Heather Jones, Morey Blinder, Milan Anadkat

  KEYWORDS: Sickle Cell Disease; Leg Ulcers; Pseudoxanthoma Elasticum; Nitric Oxide Deficiency; Hydroxyurea

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.3 No.3, September 16, 2013

  ABSTRACT: Sickle cell disease is an inherited erythrocyte disorder affecting multiple organ systems. As individuals are living well into middle age due to advances in diagnosis and treatment, further disease-related complications are being recognized. This article reviews the cutaneous manifestations of sickle cell disease including leg ulcers and acquired pseudoxanthoma elasticum.